MEDIFAST INC
As of Oct 22, 2026, MEDIFAST is in Stage 2, the uptrend phase, now in week 7 (since Sep 8, 2026). It closed at $12.17, 7.5% below its 52-week high and above its 200-day average, which is rising.
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 5 in Personal Services · #1 of 102 in Consumer Discretionary
Is MED early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
MED among Personal Services5th of 13 by relative strength
All 13 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | FTDR | Stage 2 · wk 19 | 75 | +16.3% |
| 2 | SCI | Stage 3 · wk 2 | 57 | +7.5% |
| 3 | HRB | Stage 2 · wk 13 | 55 | +17.7% |
| 4 | RGS | Stage 2 · wk 2 | 51 | +7.1% |
| 5 | MED | Stage 2 · wk 7 | 50 | +1.8% |
| 6 | CSV | Stage 4 · wk 17 | 41 | +16.6% |
| 7 | BFAM | Stage 4 · wk 5 | 33 | +6.7% |
| 8 | ROL | Stage 4 · wk 27 | 30 | +8.7% |
MEDIFAST: quick answers
What stage is MEDIFAST in?
As of Oct 22, 2026, MEDIFAST (MED) is in Stage 2, the uptrend phase. It entered Stage 2 on Sep 8, 2026 and is in week 7. What the four stages mean
Is MEDIFAST in an uptrend?
Yes. MEDIFAST is in a Stage 2 uptrend. It trades 7.8% above its 200-day average, which is rising.
How far is MEDIFAST from its 52-week high?
MEDIFAST closed at $12.17 on Oct 22, 2026, 7.5% below its 52-week high of $13.15. Its 52-week low is $9.45.
How has MEDIFAST performed over the past year?
As of Oct 22, 2026, MEDIFAST is down 5.4% over the past year and up 17.0% so far in 2026.
Which sector and industry is MEDIFAST in?
MEDIFAST is in the Personal Services industry, part of the Consumer Discretionary sector.
About this companyConsumer Discretionary· Personal Services
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.